Use of High-Dose Iron in Dialysis in US Tracks PIVOTAL Trial

The 2019 landmark PIVOTAL trial that established the safety and efficacy of higher-dose iron in patients on hemodialysis had little discernable impact on US practice, which already used higher doses.

Related Keywords

United States ,New York ,United Kingdom ,Missouri ,Chapel Hill ,Canada ,Washington University ,London ,City Of ,Canadian ,American ,Astellas Pharma Fibrogen ,Iainc Macdougall ,Abhijitv Kshirsagar ,Frankm Liu ,Danielw Coyne ,Indiana University School Of Medicine ,King College Hospital ,University Of North Carolina School Medicine ,Drug Administration ,Indiana University Hospital ,Washington University School Of Medicine ,New England Journal ,Dialysis Outcomes ,Practice Patterns Study ,High Dose Iron ,Clinical Journal ,American Society ,Kidney Disease ,Improving Global Outcomes ,College Hospital ,Indiana University School ,Washington University School ,North Carolina School ,Weill Cornell Medicine ,Most Patients ,Hemodialysis ,Vascular Access ,Kidney Dialysis ,Renal Dialysis ,Chronic Renal Failure ,Hronic Kidney Failure ,Hronic Kidney Disease Ckd ,Chronic Kidney Disease ,Kd ,Dialysis ,End Stage Renal Disease Esrd ,End Stage Renal Disease ,Srd ,Renal Failure ,Enal Insufficiency ,Idney Insufficiency ,Kidney Failure ,Anemia ,Hematology ,United Kingdom Site Content ,Renal Disease ,Idney Diso ,